Sustainable Development Report 2010 02/ 01 INTRODUCTION From the President of the Management Board 04 Organisational Profile 06 Report Parameters 08 Sustainable Development Report 2010 02 ECONOMIC PERFORMANCE INDICATORS PLIVA CROATIA 12 Awards Received by PLIVA in 2010 13 Publisher PLIVA HRVATSKA d.o.o. Editor-in-Chief Tamara Sušanj Šulentić Executive Editors Sanja Fressl and Maja Lopotar Mihalinec Translation Sanja Galović Language editing Lingoteka Contributions Sustainable Development Committee members Layout Fingere, Samobor Photography PLIVA Corporate Image Library, PLIVA Magazine 0 /03 content 03 SOCIETY PERFORMANCE INDICATORS Human Resources 16 Science and Education 24 Employee Care 27 Sponsorships and Donations 34 Product Responsibility 36 Safety and Health 36 04 ENVIRONMENTAL PERFORMANCE INDICATORS Environmental Protection 44 Water Management 45 Air Emissions 46 Waste Management 46 Sustainable Development Committee Damir Šmida e-mail: [email protected] / Tamara Sušanj Šulentić e-mail: [email protected] 04/ Sustainable Development Report 2010 /05 fRom tHe pReSiDent of tHe management boaRD Dear readers, Despite turbulences in both the Croatian jobs, which is, I believe, one of its most be taken into account since PLIVA, as and international markets and a deep important aspects for Croatia. In addition a respectable partner to the Croatian economic recession in Croatia in 2010, to new employment at PLIVA, this and healthcare system, operates in a PLIVA’s operations were stable and its other similar projects considerably strategically important industry both for revenues at their 2009 levels. At the encourage further production growth the country and its citizens. Therefore, same time, PLIVA increased its gross in Croatia, especially thanks to the PLIVA’s Management Board pays special income, EBIT and net income, which possibility of a more significant attention to compliance with ethical shows the company’s significantly engagement of domestic suppliers with principles, protection of human rights, increased operating efficiency and whom we cooperate as the largest product and work process safety, competitiveness within the Teva Group, pharmaceutical company. occupational safety and health and environmental protection, requiring each primarily thanks to the increased production of finished dosage forms and PLIVA is aware of the fact that its and every one of its employees to do the active pharmaceutical ingredients, higher business success and reputation also same. efficiency, investment growth and a far depend on its working environment. better utilisation of production capacities. Consequently, it has embedded In 2010 we continued to carry out our environmental protection principles public health campaigns, make charitable The company’s exports account for into its operations, thereby contributing contributions to hospitals, support major around 80% of its sales, and its largest to the protection of health and the projects focusing on health protection export markets are Russia and the United improvement of the quality of life in the and prevention, and sponsor valuable States of America, where PLIVA’s exports communities in which it operates. conferences and symposia. We invested amounted to around half a billion kuna Through its economic decisions and almost HRK 11 million in these projects, in 2010. As the largest Croatian exporter cooperation with the local community and thus maintained their 2009 levels. to the USA, PLIVA was presented with a and the relevant state authorities, prestigious Ron Brown Award. the company is trying to find the We are, however, aware of the fact that most acceptable economical and there is room for improvement, and we In accordance with its announcements, environmental solutions to protect the shall work on these improvements and PLIVA entered a new investment cycle environment to the maximum extent. report on our achievements in our next in 2011, and plans to invest about USD An exceptionally important segment of Sustainable Development Report. 120 million over the next three to five each investment is the analysis of its years. The largest sum, i.e. almost USD potential environmental impact and the matko bolanča, mba 100 million, is earmarked for a new company invests considerable efforts President of the Management Board and production facility in Savski Marof, while to achieve an optimal harmonisation General Manager of PLIVA in Croatia USD 21 million will be invested in the between economic and environmental President of the Sustainable expansion of production capacities for requirements. Development Committee oral solid forms and creams in Zagreb. As a member of Global Compact since The project for the construction of 2007, PLIVA started a number of the new production facility in Savski initiatives that yielded positive results, Marof is being carried out as planned, and in 2010 PLIVA drafted its first and the works on the new factory are Progress Report. estimated to begin by the end of 2011. The fact that PLIVA is a company This investment will bring about multiple with the highest market share and benefits both to PLIVA and the wider the biggest number of pharmaceutical community because it will create new products in the Croatian market has to 06/ SuStainable Development RepoRt 2010 Organisational Profile In December 2008, Teva, an Israeli company, acquired Barr Pharmaceuticals and thus became PLIVA’s new owner. Today, PLIVA is a member of the Teva Group, the largest global generic pharmaceuticals company. about Pliva With 90 years of successful PLIVA’s strong product portfolio covers pharmaceutical experience, PLIVA is the following major therapeutic groups: today a member of the Teva Group, the cardiovascular, gastrointestinal, anti- largest global generic pharmaceuticals infectives, cytostatics, musculoskeletal, company. We at PLIVA are dedicated neurological and psychiatric diseases to providing our customers with high and infusion solutions. PLIVA’s leading quality, affordable medicines for a better products are Sumamed and other quality of life. azithromycin-based semi-finished and finished products, Torasemide/Diuver, PLIVA’s product portfolio includes oral Trazodone, Contrykal, Finlepsin and solid and injectable dosage forms, Cerucal. creams/ointments, over-the-counter products, cytostatics and active PLIVA’s biggest market is Croatia. Its pharmaceutical ingredients. Prescription second ranking market is Russia, and its medicines are bought by wholesalers third ranking market is the USA. These and hospitals, while over-the-counter are followed by Poland, Ukraine, Bosnia medicines are in free sale in pharmacies. and Herzegovina, the Czech Republic, United Kingdom, Kazakhstan and Hungary. Croatia Russia USA Poland Ukraine Bosnia and Herzegovina The Czech Republic United Kingdom Kazakhstan Hungary /07 Organisational Profile Management Board of PLIVA CROATIA Stakeholders The Management Board of PLIVA PLIVA pays particular attention to the CROATIA is led by its President development of strong relationships with Public health campaigns, which are Matko Bolanča. The members of the various stakeholders in its economic and organised by PLIVA in Croatia and whose Management Board are Mirjana Mesec, social environment, and especially its purpose is the prevention of diseases, Miran Denac and Zoran Bunčić. employees, citizens, the media, professional education and health improvement, are audiences (physicians and pharmacists), a good example of this practice. The President Allan Oberman and members scientific and educational institutions, public’s response to these campaigns Tim Orešković and Theo Andriessen. business partners and suppliers, non- increases every year. They are organised in governmental organisations, associations cooperation with specialised associations PLIVA’s organisation is a combination for people with illnesses and diseases and healthcare institutions (diabetes and of matrix and functional organisation, and people with special needs, and local osteoporosis associations, the cardiovascular and it is harmonised at the Teva Group communities. As PLIVA is the largest centre, public health institutes, etc.), and level. The primary organisational units drug manufacturer in Croatia, healthcare are conducted under the auspices of the in PLIVA CROATIA are Product Supply, authorities and drug regulatory agencies Ministry of Health and Social Welfare or, TAPI, Research and Development, and represent a separate stakeholder group. in the case of PLIVA’s project for collection • • Supervisory Board Organisation and disposal of expired medicines, in Commercial Operations. In addition to these units, PLIVA CROATIA also has the In line with its strategy and business cooperation with the City of Zagreb’s Office following support functions: Legal Affairs, policy, and when possible in consultation for Labour, Healthcare, Social Welfare and Human Resources, Finance, IT, Security with its stakeholders, PLIVA plans various War Veterans. and Communications. activities to enhance its relationship Share Capital with individual stakeholders on a yearly Additionally, PLIVA continuously The company’s share capital totals basis and depending on their specific collaborates with all Croatian universities, HRK 3,142,360,000.00 expectations. This primarily refers to a sponsors scholarship programmes and continuous exchange of information and supports various scientific symposia, and dialogue, but also to common projects its experts participate in proposing and of interest both for PLIVA and its wider drafting legal regulations in various fields. • environment. Scientific and Educational Institutions • Ruđer Bošković Institute • Croatian Academy of Sciences and Arts • Croatian Society of Chemical Engineers • Croatian Academy of Medical Sciences • Universities and schools (Faculty of Science, Faculty of Biotechnology and Food Technology, Faculty of Pharmacy and Biochemistry, Faculty of Chemical Engineering and Technology, Medical School, Secondary School for Health Care Providers) • Students Government Market • Customers/Healthcare institutions • Wholesalers • Hospitals Employees • Pharmacies • All employees • Citizens • Trade unions PLIVA • Ministry of Health • Croatian Health Insurance Institute • Agency for Medicinal Products and Medical Devices • City of Zagreb • Financial Agency Media and General Public • Journalists Market • Citizens • Agencies • Business partners • Suppliers • Croatian Chamber of Commerce • Croatian Employers’ Association 08/ Sustainable Development Report 2010 /09 Report Parameters Report Parameters PLIVA has published its annual Sustainable The Sustainable Development Report Although they include some data required Development Report for nine consecutive for 2010 covers economic, society and for Level B, all reports to date can be years to make its operations as transparent environmental performance indicators. It classified as Level C. as possible and to present the results has been drafted in line with the 2006 achieved under the implementation of the Global Reporting Initiative guidelines. sustainable development principles to the public. The Sustainable Development Report is drafted for PLIVA in Croatia. Contact persons for the Sustainable Development Committee: Tamara Sušanj Šulentić Damir Šmida Communications Director, Director of Facility Management, [email protected] [email protected] 010/ SuStainable Development RepoRt 2010 Economic Performance Indicators /011 012/ Sustainable Development Report 2010 Business Results of PLIVA CROATIA in 2010 Despite turbulences in both the Croatian and international markets and a deep economic recession in Croatia in 2010, PLIVA’s operations were stable and its revenues at their 2009 levels. • At the same time, PLIVA increased its manufacturing sites for all of Teva and that gross income, EBIT and net income, which they manufacture the products intended shows the company’s significantly increased for exports to the USA, the largest global operating efficiency and competitiveness pharmaceutical market where PLIVA’s last within the Teva Group, primarily thanks to year’s exports amounted to almost half a the increased production of finished dosage billion kuna. forms and active pharmaceutical ingredients, higher efficiency, investment growth and a far • better utilisation of production capacities. the Croatian market. Its second ranking PLIVA generated the highest sales from market is Russia, and its third ranking market PLIVA holds the leading position in the is the USA. They are followed by Poland, Croatian market, both in the categories of Ukraine, Bosnia and Herzegovina, Ireland, prescription medicines and of over-the- the Netherlands, Kazakhstan and the Czech counter medicines. It is ahead of its first Republic. • competitor by around 20% in each of these segments, in both financial and value terms. • The most recent business results confirm that investment cycle in 2011, and plans to invest positive trends have continued in the first half about USD 120 million over the next three of this year. to five years. The largest sum, i.e. almost As announced, PLIVA entered a new USD 100 million, is earmarked for a new • In 2011 PLIVA had almost 200 molecules production facility in Savski Marof, while USD in more than 290 pharmaceutical dosage 21 million will be invested in the expansion forms included on the reimbursement list of production capacities for oral solid forms of the Croatian National Institute for Health and creams in Zagreb. The equipment for Insurance, and it plans to register a large the production facility in Zagreb has been number of new products. Since PLIVA is already ordered and the design activities are the only company in Croatia with vertically underway. The machines are expected to be integrated production, it can at any time offer installed in the second half of 2011. value added products, both in terms of new delivery systems and innovative routes of • administration and in terms of new medicinal production facility in Savski Marof is also carried products. out as planned. The necessary documents are The project for the construction of the new drafted and the requisite approvals and permits • The prescription medicines hold the highest procured. According to our estimates, the share in the sales structure, and Sumamed works on the construction of the new factory has continued to be the leading product. It is will bring about multiple benefits to both followed by other finished and semi-finished PLIVA and the wider community. azithromycin based products, trazodone, ambrobene, torasemide, cerucal, diuver and • corinfar. considerably encourage further production This and other similar projects may growth in Croatia, especially thanks to new The share of PLIVA’s exports grew to employment at PLIVA and the possibility of almost 80%, primarily due to the fact a more significant engagement of domestic that its manufacturing sites in Zagreb suppliers with whom we cooperate as the and Savski Marof became the strategic largest pharmaceutical company. • /013 Business Results Number of Employees Organisations compete against one ISO 13485 another and are evaluated against five On 31 December 2010 PLIVA had 1861 criteria: PLIVA received the ISO 13485 certificate employees or 11.5% less than in the end (1) Service Leadership; for its antiseptic and disinfectant of 2009. (2) Service Culture; product range, which will enable the (3) Service Positioning; harmonisation with European standards (4) Service Relationship Marketing and and appropriate labelling of its products. (5) Service Recovery The certificate covers development, Best in Customer Service Award All companies with headquarters or a production, warehousing and sale and PLIVA RECEIVED THE AWARD FOR subsidiary based in Croatia are eligible to disinfectants and biocides. EXCELLENCE participate in this competition. Awards Received by PLIVA in 2010 In today’s increasingly global competitive On the basis of this certificate and in environment, quality customer service accordance with Directive 93/42/EEC, is more critically important than ever some of PLIVA’s products will bear the before. The Best in Customer Service appropriate labelling, which will facilitate Award is a national competition, their future launch in European markets. developed to reward and recognise organisations that demonstrate The First Choice Employer excellence in customer service. The purpose of the award is to promote According to the results of the “First excellence, best practices, leadership, Choice Employers 2010” survey creativity and innovation. comprising more than 2000 respondents and conducted by the employment website MojPosao in February, PLIVA was among the top ten, which shows a continuously good perception of the company among respondents. 014/ SuStainable Development RepoRt 2010 Society Performance Indicators /015 016/ Sustainable Development Report 2010 Employment Figure 1 Employee structure by gender and age on 31 December 2010 MEN WOMEN Up to 30 years old 102 employees Up to 30 years old 127 employees From 30 to 34 years old 82 employees From 30 to 34 years old 171 employees From 35 to 39 years old 127 employees From 35 to 39 years old 171 employees From 40 to 44 years old 152 employees From 40 to 44 years old 205 employees From 45 to 49 years old 182 employees From 45 to 49 years old 225 employees From 50 to 54 years old 107 employees From 50 to 54 years old 107 employees From 55 to 59 years old 55 employees From 55 to 59 years old 14 employees Older than 60 8 employees Older than 60 0 employees Human Resources PLIVA’s strength lies in the diversity, are relatively specific and for many employees, i.e. 764 or 41.6%, were in expertise and commitment of its positions, especially those in production, the age range of 40-49. employees. The credit for its success quality assurance and research and has gone to them for many generations. development, on-the-job learning A detailed gender and age structure is PLIVA has almost half a century long assures the best performance. given in Figure 1. tradition of a careful selection of new employees, and pays special attention to On 31 December 2010 PLIVA CROATIA recruitment processes. Ltd. had 1835 employees. Our goal is to attract candidates with The company employs 1020 women, superior capabilities, motivated for or 55.6%. As the majority of PLIVA’s continuous learning and professional activities are located in Zagreb and its development and able to successfully surroundings, 98.5% of our employees cooperate with their co-workers and work in Zagreb and its surroundings, and others. Most often we employ recent 1.5% in Slavonia and Baranja, Dalmatia, graduates and invest in their development Istria and Primorje, Gorski Kotar and and further professional advancement. Lika. The average age of employees in One of the reasons is that our operations 2010 was 41 years old. The majority of /017 Human Resources In 2010, the number of employees with open-ended contracts was 1802 or 98.2% and those with fixed-term contracts was 33 or 1.8%. PLIVA employees with fixed-term contracts have the same labour rights and benefits as those with open-ended contracts. As far as PLIVA’s educational structure is concerned, the employees with graduate and postgraduate degrees (M. Sc., M.A., Ph.D.) account for more than a third, i.e. 41.7%. Figure 2 Educational structure on 31 December 2010 7.2% 36.7% M.Sc., M.A., Ph.D. B.Sc., B.A. or two-year post-secondary 45.7% 10.3% High school Skilled, semi-skilled and unskilled workers Figure 3 Age structure of employees whose employment was terminated in 2010 13% 16% 40% 28% 3% up to 29 years old from 30 to 39 years old from 40 to 49 years old from 50 to 59 years old older than 60 years As in the years before, the trend of an In 2010, 321 employees left PLIVA. Women accounted for 53% of employees increasing share of highly educated The fluctuation rate was 16.1%. The whose employment contracts were employees and a decreasing share of most common cause for termination terminated, but their share in the total skilled, semi-skilled and unskilled workers of employment was the termination of number of employees is also somewhat in the total number of employees employment contracts by the employer higher. continued in 2010. In 2010 PLIVA due to the restructuring of business CROATIA recruited 35 employees, mainly operations following the company’s in marketing and sales, production and takeover by Teva. quality control. 018/ Sustainable Development Report 2010 Education and Training Figure 4 Structure of training costs at PLIVA CROATIA Ltd. 12% 7% 55% Literature Seminars and conferences Accompanying costs 2% IT training 12% Foreign languages Costs 2% Professional advancement, vocational exams 10% Postgraduate studies High-quality and educated employees multidisciplinary task forces, seminars, PLIVA is dedicated and pays special are one of the strongest sources of conferences, postgraduate and specialty attention to continuous training PLIVA’s success and labour market studies and foreign languages and and education. The training system competitiveness. computing courses. We make sure covers activities focused on planning, that the employees occupying expert organisation and realisation of training PLIVA is committed to providing positions attend conferences and programmes, and has a substantial annual each employee with the opportunity symposia and have access to the relevant budget. In 2010, the budget for training to acquire the knowledge required literature covering their fields of work. programmes for employees of PLIVA CROATIA Ltd. amounted to almost HRK for their employment role and it therefore supports and encourages For the past few years PLIVA has paid 5.35 million or approximately an average lifelong learning. As pharmaceutical special attention to development of of HRK 2,910.00 per employee. These operations are specific, PLIVA provides managers and employees who are costs do not include literature costs, additional on-the-job training to its new high performers with key talents. The which amounted to an additional HRK employees, for example, in production specific goals of these programmes 382,000.00. or quality assurance, and invests in their are: identification, development and further professional advancement. maintenance of key talents; development and definition of a succession plan for PLIVA supports both on-the-job learning high and middle management, and and other forms of training conducted development and implementation of through coaching and mentorship, managerial and leadership skills. /019 Human Resources PLIVA’s strategy is to continuously invest A large number of e-learning courses (i.e. in the development of each and every over 50), which enable the employees one of its employees, thus offering them to take a more flexible approach to the a number of opportunities to identify and acquisition of new knowledge, is the reason develop their own potential. why the total number of training hours decreased despite the increased number of The company organises the preparation training topics. and exams for those employees whose job positions require them to pass vocational or PLIVA CROATIA has its own learning state exams. centre, which offers tailored programmes and encourages the exchange of Given the specificities of the knowledge and communication in pharmaceutical industry and the the company. In 2010, it organised continuously and rapidly changing 27 seminars covering various topics – regulatory requirements, special attention from expert seminars to those for the is also paid to regular GMP (Good development of general and business Manufacturing Practice) training of competencies – which were attended by employees. The GMP training covered over 230 employees. Seminars are held PLIVA’s management is committed to around 1200 employees, who on average by both external and PLIVA’s experts. continual professional development, attended 20 hours of GMP training in The advantage of these programmes is for which they were given an excellent 2010. better adjustment to our needs and the opportunity in February 2010. Guest promotion of knowledge and information speaker Leandro Herrero presented the rate exchange within the company. of changes in the business environment As this is the obligatory in-house training, Leandro Herrero at PLIVA the corresponding data are not included in in an original and interesting manner, and any further analysis. Due to a demand for encouraged them to embrace outside the more flexible forms of training, e-learning square thinking and search for new trends courses were also offered to employees. and innovative and creative solutions. 020/ Sustainable Development Report 2010 Figure 5 The share of various training programmes with regard to employees of different qualifications 120% 100% 80% 60% 40% 20% 0% Skilled, semi-skilled and unskilled workers B.Sc., B.A. or two-year post-secondary M.Sc., M.A., Ph.D. Mandatory training IT courses Vocational training Languages Conferences/seminars Postgraduate studies 70% 60% 50% 40% 30% 20% 10% 0% Up to 30 years old 31-40 41-50 51 and older Figure 6 The share of various training programmes with regard to employees of different age In 2010 PLIVA’s employees attended 31 certain jobs, e.g. forklift operators, As far as the share of various training hours of training on an average. operators of reactors with compressed programmes with regard to employees The employees of different qualifications gases, etc. The employees with university of different age is concerned, younger attended different training programmes. qualifications more often attended various employees mostly focus on vocational Skilled, semi-skilled and unskilled workers professional programmes such as seminars, training programmes, i.e. postgraduate mostly attended training required for conferences and postgraduate studies. studies, seminars and conferences. /021 Human Resources Compensation and Benefits The compensation and benefits system is a part of PLIVA’s performance management system which is applied to all employees, regardless of their job or position in the company. The compensation and benefits system covers of the entire compensation and benefits the system of base pays, which are based system and training of managers in its on job complexity and responsibilities, the implementation fall under the responsibility performance management system, which of Human Resources, which also ensures its yields a variable part of the pay and the objective and correct implementation. system of other benefits. PLIVA’s employees are also entitled to From year to year each and every one of many other rights, which are defined by the PLIVA’s employees may have significant Collective Agreement, such as: systematic influence over their salary by their work, preventive check-ups, years-of-service awards engagement and achievements. There is for more than 10 continuous years of service also a system related to the long-term with the employer, annual leave allowance, a achievement of company results. This system Christmas bonus, Christmas gifts for children includes share options and it is intended for up to 15 years of age if they have health PLIVA’s highly positioned managers who are insurance via their parent working at PLIVA, responsible for defining and realising PLIVA’s support in the purchase of medicinal products business strategy. and medical aids, aid in the event of disability, death of a family member, or support for the Creation, development and implementation family of a deceased PLIVA employee. Scholarships and Practice Although most training activities are focused on training of PLIVA’s own employees, education for PLIVA has always represented much more. PLIVA pays a lot of attention to the attraction equipment. Students may also count on of its future employees as early as during professional support in writing bachelor’s their schooling. The interested pupils and theses and by working on various projects get students may do work experience at prepared for their future jobs. PLIVA, and for them this is one of the first opportunities to put acquired theoretical Furthermore, PLIVA also has a long knowledge into practice by using the scholarship tradition to attract students with state-of-the-art technologies under the superior achievements and capabilities, and supervision of their PLIVA mentors. In earmarks considerable funds for scholarships 2010, 32 students did work experience at for students who have the competencies we PLIVA. As most of them are just beginning need. In 2010, PLIVA granted scholarships to grasp all the types of assignments to be to 10 students, mostly from the University performed by the employees having the of Zagreb’s Faculty of Chemical Engineering same or similar qualifications, practical work is and Technology, Faculty of Pharmacy and also an opportunity for them to define their Biochemistry, Faculty of Food Technology professional interests and ambitions. and Biotechnology and Faculty of Mechanical Engineering and Naval Architecture. PLIVA also provides support to a considerable number of students in writing seminar papers There is also a special scholarship programme and bachelor’s theses, enabling them access for children who have lost one or both to literature and various databases and learn parents formerly employed by PLIVA something new by using new methods and CROATIA Ltd. 022/ Sustainable Development Report 2010 Employment The Collective Agreement defines the following employee rights, which are not stipulated by the law or whose duration or amount stipulated by the law is shorter or lower: 1. period of notice – depending on years of service with the employer – up to 6 months; 2. s everance payment – regular severance payment amounting to a half of the the month prior to the beginning of the sick leave; 12. p reventive medical examinations at least once in two years; 13. p ecuniary compensations to employees average monthly gross salary paid and their family members in the case to the employee three months prior of: to termination of their employment - employee’s death, contract for each year of service with - death of an immediate family the employer; 3. severance payment –incentive severance payment depending on years of service with the employer and amounting to 8 to 27 average monthly gross salaries member, - employee’s disability, - purchase of medical appliances or for prescription charges, if on a sick leave exceeding 90 days; of the employees in the Company, paid 14. one-off allowance for annual leave; three months prior to termination of 15. years-of-service award; the employment contract by mutual 16. pension package; agreement; 17. cash grant for a Christmas gift for 4. annual leave lasting 30 days, or over children; 30 days in the case of some special 18. Christmas bonus; family obligations or for some special 19. p aid public transportation costs; categories of employees; 20. car allowance for using private cars for 5. Saturday shall not be included in the duration of the annual leave; 6. incentive part of the salary; 7. permanent monthly bonus depending on type of performed assignments business purposes; 21. exemption of employee regress liability for a damage caused to a third party out of ordinary negligence; 22. e mployer’s liability for damage caused (higher for jobs where pay is determined to the employee, i.e. for occupational on the basis of job complexity injury, occupational disease or disease coefficient); in connection with the principle of 8. especially increased pay base for very difficult working conditions; 9. increased salary for work on Saturdays and work in shifts; 10. allowance amounting to salary for the previous month for: actual liability (causation); 23. the obligation to draft a layoff management programme in the case of termination of at least five employment contracts in a 6-month period. - annual leave, - paid leave of absence, Additionally, the Bylaw on Labour - statutory national holiday, Relations defines the employee right to - training, prequalification and the paid leave of absence for training. The professional training on the basis of Bylaw on Employee Earnings defines the the employer’s decision, performance appraisal system and the - standstill not caused by an employee; 11. sick leave allowance paid by the employer – 80% of the salary paid in system for bonus payment, and the right to compensation for extraordinary work achievements. Human Resources Diversity and Equal Opportunity The Management Board is made up of four members, of whom one is female (25%) and three are male (75%). Human Rights Non-discrimination In 2010 no incidents of discrimination or complaints related to harassment were reported. /023 024/ Sustainable Development Report 2010 Science and Education Among a number of symposia that PLIVA ADIVA - Advice for Health is a new sponsored or supported financially in professional training programme for 2010, we would like to mention the pharmacists organised by the Croatian Fifth Croatian Congress of Psychiatry Chamber of Pharmacists and PHOENIX held in Šibenik from 29 September to Farmacija. The goal of the ADIVA programme 3 October 2010. This is the largest and is to help pharmacists in providing advice already a traditional meeting of Croatian to patients and thus improve the general psychiatrists, dedicated to the preservation perception of pharmacists and promote and improvement of mental health. Its pharmacy in Croatia. Additional pharmacist Positive Concert Powered by PLIVA in 15 topics covered all important fields of services and ADIVA – Advice for Health bring Fight against AIDS psychiatry, and included the presentation about a number of benefits to all citizens, of the Medicus issue dedicated to providing them with professional and easy to PLIVA considerably contributed to AIDS Addiction Diseases, Childhood and understand advice on the appropriate use of prevention in the week dedicated to the Adolescent Psychiatry and Psychotherapy. medicinal products, prevention of diseases fight against this disease, which culminated and improvement of healthcare. with the “Positive Concert” organised The Fourth Croatian Congress of The values and the quality of this by the Croatian Association for Fight Pharmacy with International Participation programme were recognised by more than Against HIV and Viral Hepatitis (HUHIV, was held in the organisation of the 700 pharmacists from 530 pharmacies Hrvatska udruga za borbu protiv HIVa Croatian Pharmaceutical Society in from all over Croatia. The partner in the first i virusnog hepatitisa) and supported by Opatija. It attracted pharmacists from cycle of this programme was PLIVA CROATIA the Ministry of Health and PLIVA as its pharmacies and hospitals, universities Ltd., and the topic of the programme was principal sponsor. Through a number of and educational institutions, state and acute respiratory diseases, with a special workshops and lectures and by providing regulatory authorities and those from the focus on the prevention and suppression professional support at Cvjetni trg from 24 pharmaceutical industry, i.e. nearly 900 of seasonal and pandemic H1N1 flu virus. November to 1 December 2010, HUHIV of them from 15 countries. The Congress Gastrointestinal diseases were the topic of and PLIVA enabled citizens to become was held under the slogan “Challenges in the second programme cycle. informed about HIV, AIDS and hepatitis, the pharmaceutical science and practice”. The programme covered the latest HIV and hepatitis testing, prevention, Competition in Consulting Skills achievements in pharmaceutical and protection and treatment, as well as about all important aspects of communication related sciences and pharmacy practice The final day of the competition in consulting and relationships with people who are HIV news. Special attention was paid to the skills, a professional training programme for and hepatitis positive. Under the slogan harmonisation of pharmaceutical training, pharmacy students and pharmacists, was “Do not discriminate – learn more” and regulatory requirements and pharmacy held at the University of Zagreb’s Faculty of through other educational and sports practice with those in Europe, which is Pharmacy in November, with PLIVA as the activities, in particular a hockey match especially important given the preparations principal sponsor. The competition lasted between Medveščak and Linz, all citizens for Croatia’s accession to the European four days and consisted of a presentation of were invited to support this commendable Union. PLIVA’s history and products, and lectures action. A concert was held in the end of about communication skills. the week and its purpose was to raise On the last competition day, the 15 awareness among young people and finalists were required to provide encourage them to be sexually responsible. appropriate therapy to real patients in a By respecting and protecting both real pharmacy setting. In this way PLIVA themselves and others they may stop the invests in the professional development of spread of the HIV virus, and by getting future pharmacists, i.e. its potential new informed they may help in the fight against colleagues. prejudices associated with this disease. /025 Science and Education www.PLIVAzdravlje.hr: Application for Mobile Phones PLIVA’s portal www.PLIVAzdravlje.hr is the first and the leading portal in Croatia intended for the public. The portal provides up-to-date, reliable and trustworthy information and its cooperation with the leading Croatian medical and other renowned experts guarantees the quality of its contents. Applications for Mobile Phones PLIVAzdravlje on iPhone The PLIVAzdravlje portal recognised the portal, provides information about the demand of an increasing number of appropriate nutrition and food and their iPhone/iPod touch users and it is the effects on individual diseases. first health portal giving its readers an opportunity to use these new applications. Furthermore, as we were increasingly contacted by users of Android-based devices, Since May 2010 PLIVAzdravlje has been we decided to develop the application available free of charge on mobile phones. for Android operating systems, which The Virtual Atlas for iPhone was one of the continuously increase their share in the first Croatian iPhone applications and the first Smartphone market and which are expected iPhone application covering health issues. on the market at the beginning of 2011. As the interest of our users exceeded PLIVAzdravlje has therefore become the all our expectations, we developed health portal that enables the use of applications for various other contents iPhone/iPod touch applications. The App of our portal. By the end of 2010 we Store was enriched by PLIVA’s Virtual developed RRS PLIVAzdravlje for iPhone/ Atlas, PLIVAzdravlje news and Nutrition by iPod Touch, an application which enables Disease applications. readers to view articles and news in either abridged or full format. The Nutrition by All these applications are free and easy to Disease application, just like the one on use. Atlas mišićno-koštanog sustava MUSCULOSKELETAL Atlas RSS PLIVAzdravlje RRS PLIVAzdravlje 026/ SuStainable Development RepoRt 2010 On-line Courses on the PLIVAmed.net Portal The potentials of internet use gave a completely new dimension to the continuous training of physicians, primarily through a multimedia approach and interaction. Interactive and dynamic web content encourages self-learning, which is the basis for the lifelong learning of physicians and a considerable time saver, irrespective of the place of work or residence. Quality online tests on the PLIVAmed. on the PLIVAmed.net portal. The analysis net portal enable physicians in Croatia to of data is facilitated because all answers are check on their own medical knowledge in centrally stored and statistically processed, a simple way and earn points for license and each test is entered in the database. So renewal. far 5900 physicians have taken our courses, The purpose of the on-line learning on the which covered various medical fields. The PLIVAmed.net portal is to simplify license success rate has been 81%. Continuous renewal by using internet technology. learning is an obligation of all physicians in Continuous learning and the collection of Croatia, and PLIVA’s free on-line courses points for license renewal for independent on Plivamed.net show that the target work is an obligation of all physicians in population is highly interested in this type of Croatia. Each successful course on the education. The main reasons are practicality PLIVAmed.net portal gives five points, and the possibility of interactions between and the number of courses posted on authors and course attendants. This is the portal by the end of 2010 was 26. reason enough to organise such courses Hypothetically, physicians can renew their in the future and thereby continuously licences exclusively by taking courses on the enhance the quality of education. PLIVAmed.net portal, and thus considerably save time and other resources. On the basis medicus of the texts posted on the portal, mentors draft multiple-choice tests with 50 test In 2010 we published two issues of questions (one correct answer out of five the MEDICUS journal. Adolescent possible choices), of which at least 30 health has always been a hot topic, (60%) should be correct for a pass. With so therefore in 2010 we published its each successful test five points are gained in sequel. The other issue was dedicated to accordance with the Chamber’s Bylaw. The the pharmacotherapy of cardiovascular courses are primarily intended for general diseases, given their high morbidity and practitioners and family medicine physicians. mortality rates. Medicus has continuously After the course is completed, physicians offered new knowledge from the fields can also find guidelines for further of medicine, pharmacy and public discussions. The test results are immediately health. It has served as a link between displayed on the screen, and instructions various medical specialties, and as such on how to proceed are sent by email. The used in everyday work by both general course participants may communicate in practitioners/family physicians and writing with their mentors throughout the specialists. Medicus has been also included course. Each on-line test is published in in the bibliographical database EMBASE/ Liječničke novine (Calendar of Events) and Excerpta Medica. /027 Employee Care Employee Care PLIVA’s efforts are continuously focused on occupational safety and health (OSH), and it is committed to constant improvements in safety at work by ensuring safe work conditions, reducing occupational injuries and preventing occupational diseases, which all contributes to the creation of a pleasant and satisfying work environment. Health and Safety Safety at Work OSH Management System In 2010 safety-at-work processes focused The OSH system has been implemented on the activities whose goal was to in the business operations system and eliminate and reduce occupational risk, harmonised with legislative requirements: reduce occupational injuries, and protect • the health of employees and their working and living environments. This goal was The Management Board of PLIVA, as the employer. • Its OSH representatives (managers at achieved by implementing measures different management levels), who are that upgrade safety levels and improve given the relevant authorisations to employee health. implement the OSH rules and measures. • The organisational unit Occupational The basic activities included further Safety and Health and Environmental regulation of the OSH management Protection provides professional support system through the drafting and adoption to the employer, its representatives, of a number of documents, internal employees and their OSH compliance audits of OSH implementation, planning officers, and conducts internal audits of safety-at-work processes as integral work processes within the work plan, training the implementation of OSH measures. • The Occupational Safety and Health of all those involved in safety at work Committee is an advisory body of PLIVA’s (OSH representatives, compliance officers Management Board which: and experts), incorporation of safety at - promotes continuous improvements work rules during the introduction of new in OSH; products or transfer of old products, OSH- - recommends the implementation of relevant preventive measures, monitoring certain OSH rules to the employer; of the occupational health status, - promotes the policy of prevention of supervision of the OSH implementation occupational injuries and diseases; and measures for further improvements. - supervises the implementation of OSH Work risks are integral parts of production - supervises health protection of measures; processes. Sometimes they cannot be eliminated, but they can be minimised. employees; etc. • Occupational Safety and Health Consequently, safety measures are integral Compliance Officers have to act in parts of work processes. Therefore, a the interest of employees and monitor proactive approach and a set of safety- the implementation of OSH rules and at-work measures should be integrated measures in the units in which they are into everyday routine activities to minimise these risks. appointed. • Employees also have certain OSH obligations and rights that are stipulated by the law and the Collective Agreement. 028/ Sustainable Development Report 2010 The OSH Implementation Occupational Safety and Health at PLIVA is • testing of work equipment; continuously ensured through: • taking care of employee health; • • reporting to the Management Board, Hazard assessments and their revisions drafting of hazard assessments and OSH representatives (managers on all are drafted continuously. They analyse, their revisions, i.e. the assessment of management levels), employees and their primarily from safety and health aspects, OSH compliance officers; various jobs and residual workplace risks. motivating employees to apply safety-at- On the basis of their results, the measures work rules in their work; to remove or reduce residual risk, timelines, participating in projects related to the and responsibilities are defined. the residual workplace risk regarding occupational injuries and diseases; • internal OSH audits; • OSH training of employees, and of OSH • • representatives and compliance officers; construction and reconstruction of providing work tools with implemented facilities and work equipment or those safety-at-work rules (measures); related to product introduction or transfer • applying safer technological processes; by embedding safety-at-work rules in • embedding safety-at-work rules in order to ensure technical solutions for • their implementation; design, construction and reconstruction • Hazard Assessments of facilities and other work equipment; • OSH documentation and records; testing of work environment; • external audits by labour inspectors. /029 Employee Care Healthcare Internal Audits External Audits The OSH status is determined on the basis The OSH status is also determined by Pliva takes care of its employees’ health of both the rate of occupational injuries audits carried out by state inspection through: and the internal audits carried out by the services. - continuous health supervision of OSH experts. Internal audits are one of the In 2010 PLIVA was audited by a number of employees working under special important indicators of the OSH status. OSH services, including a Coordinated Audit work conditions (with the increased They are carried out to determine whether by several services at the Savski Marof site, engagement of occupational medicine the OSH system meets legal requirements which did not find any incompliances with specialists who supervise working and and employer’s bylaws. They also reveal OSH legal requirements. ancillary rooms and review hazard assessments and minutes of work deficiencies and define the timeline and responsibilities for their rectification. Training environment testing prior to periodic examinations), In 2010 either full or targeted internal audits were carried out in different Raising the awareness of the necessity for organisational units. OSH implementation is based on various and continuous OSH training programmes - preventive medical examinations of all PLIVA employees, - cooperation with occupational medicine that are intended for: specialists (medical examinations, - employees, workplace examinations, assistance - OSH compliance officers, in drafting risk assessments, expert - OSH representatives (managers), -p rofessional training of employees in the performance of certain assignments. In 2010 various training programmes were conducted. assistance, etc.), - organisation and implementation of active medical vacation in medical recreation centres and health centres, - organisation and implementation of vaccination against infectious diseases, Reporting - employee training in the provision of first PLIVA ensured reporting on the established - organisation of various free time aid, OSH status through standardised reports activities via PLIVA’s Sports Club, etc. on: -O SH status, Employee Motivation -o ccupational injuries and diseases, -a ccidents and disturbances in technological processes, -h azards and deficiencies determined In order to raise the level of employee motivation in implementing safety-atwork rules, i.e. for working in a safer by internal audits, inspections of way and respecting working discipline, occupational injuries or accidents, and PLIVA established the annual “Award testing of work environment and work for Occupational Safety and Health tools, Achievements“. In 2010 both individuals -n ew OSH regulations, rules and knowledge. and teams were presented this award. 030/ Sustainable Development Report 2010 The OSH Status The status of safety at work in 2010 may be established on the basis of the following results: One of the important indicators of the safety-at-work status is a number of injuries per 1,000 employees. Table 1 Workplace injuries per 1,000 employees Year Average number of employees Number of workplace injuries* Number of workplace injuries per 1,000 employees Total number of injuries* Number of total injuries per 1,000 employees 2006 2226 16 7.2 34 15.3 2007 2727 10 3.7 27 9.9 2008 2818 11 3.9 29 10.3 2009 2326 15 6.4 22 9.4 2010 1909 12 6.3 23 12.0 20 15 10 5 0 2006 2007 Total injuries 2008 2009 2010 Workplace injuries * - Both lost time and other injuries Workplace injuries - injuries that occurred at the workplace Out of workplace injuries - injuries that occurred on the way to and from work, business trips Total injuries = workplace injuries + out of workplace injuries The data given in Table 1 shows that the year before. The number of total injuries injuries, i.e. injuries beyond the employer’s number of workplace injuries per 1,000 per 1,000 employees grew by 2.6 due to control. employees fell by 0.1 with regard to the the increased number of out-of-workplace /031 Employee Care The number of workplace injuries per one million hours worked (LTA – lost time accident) is also an important indicator of the OSH status. Table 2 The number of injuries per million hours worked (LTA). Year Hours worked Number of workplace injuries* LTA 2006 3,998,712 16 4.00 2007 4,137,595 10 2.42 2008 4,748,217 10 2.11 2009 3,903,018 12 3.07 2010 3,090,053 9 2.91 * Number of workplace injuries that resulted in one or more days of absence from work 5 4 3 2 1 0 2006 2007 2008 2009 2010 Number of injuries/million of realised hours In 2010 the LTA was down 0.16 Protection, managers of injured measures to be taken to prevent their compared to the year before. employees and OSH compliance officers reoccurrence. The OSH experts, the Occupational inspect all cases of workplace injury to Safety and Health and Environmental accurately determine their cause and 032/ Sustainable Development Report 2010 Health and Disability Care accordance with special regulations, PLIVA general health of employees, along with also organised and conducted 446 sanitary workplace morale. Active medical leave is As in the years before, in 2010 health safety examinations, which are obligatory on provided under the terms of the Collective protection of employees was ensured an annual basis for employees who come Agreement on Occupational Safety and through contracts on the provision of or may come in contact with medicinal Health. In 2010, 51 employees took healthcare services with occupational products and bulk pharmaceuticals. We also advantage of the active medical leave medicine specialists and in line with risk organised 256 examinations for employees programme. assessments and the Procedure on Jobs with who use computers while working. Special Working Conditions. PLIVA organised Preventive medical examinations were 722 periodic medical examinations for organised for 1201 employees. employees working under special working Active medical leave programmes are an As in the years before, PLIVA organised flu conditions, and it takes the necessary action important part of healthcare, and their vaccination before winter. The number of based on the results of examinations. In purpose is to improve the fitness and employees who used this option was 176. PLIVA’s Blood Donation Volunteers As in the years before, in 2010 PLIVA cholesterol tested at these events. In order organised four blood drives in cooperation to additionally motivate the employees with the Croatian Red Cross and the for this charitable cause, we organised an Croatian Institute of Transfusion Medicine. educational trip to Crikvenica. The Blood In 2010, the number of blood donators Donation Volunteers continue to work on slightly decreased. However, the trend the promotion of blood drives and regularly of an increased response among young invite all PLIVA employees and retired employees and women continued. Those employees to join them. volunteering to donate blood can have their blood glucose, triglycerides and Year Number of blood donors 2008 672 2009 662 2010 618 Other /033 Employee Care Christmas Lunch and Party for Employees As in previous years, PLIVA organised Best Club, where it also presented the achievements in occupational safety and a lunch for all employees on the eve annual PLIVA Awards. health. of the Christmas holidays. This was an In line with its Bylaw on PLIVA Award, In the middle of December PLIVA opportunity for them to spend some the nominations were received in three traditionally organises a free movie time with their directors and managers categories: for exceptional results in screening for the children of its in an informal and relaxed atmosphere. 2010, for a long time contribution employees. This time it was MaximUm, PLIVA also threw an evening party at to the Company, and for outstanding dubbed into Croatian. After-Work Party on Fridays December is a month of gift giving and spending every Friday, whenever we atmosphere of the first after-work party, spending more time with colleagues, could, enjoying snacks and refreshments decorating a Christmas tree with their friends and all dear people. with our co-workers at PLIVA Café in good wishes for the year to come. This is why we decided to bring some of the Central Office Building. Many of this Advent spirit and warmth to work, our colleagues enjoyed the cheerful 034/ Sustainable Development Report 2010 Sponsorships and Donations PLIVA is known for the help it gives to a large number of institutions and organisations taking care of those who need it most. In accordance with its sponsorships and donations policy, in 2010 it earmarked HRK 11 million for a number of healthcare and prevention related projects. It did not forget projects in the fields of education, science, environmental protection, culture and sports. However, the majority of our projects are health and advice on the prevention and focused on healthcare and prevention. treatment of cardiovascular diseases and In 2010 PLIVA continued to organise its diabetes from physicians and members already traditional public health campaigns of the Croatian Federation of Diabetes under the slogan “Dedicated to health”. Societies. In cooperation with the Multiple The purpose of these campaigns is to show Sclerosis Society and Europa Donna Croatia, that prevention, education and leading a an organisation fighting breast cancer, we healthy life are the first and the right steps organised the sale of flowers to raise funds to health. The actions were held in the four to help their members. biggest cities of Croatia, i.e. Zagreb, Split, Rijeka and Osijek, in the middle of April For the fourth consecutive year, PLIVA and under the auspices of the Croatian Ministry the Public Health Institute of the Međimurje of Health and Social Welfare. County held a similar action on the occasion of World Health Day in Čakovec in late It is a well known fact that smoking, stress, September. With the help of physicians and being overweight and hypertension are nurses from the County Hospital Čakovec main risk factors for the development and Health Centre Čakovec, citizens could of cardiovascular diseases, which can be also have their blood pressure, sugar and prevented or at least alleviated by adopting triglycerides tested, and receive free medical a healthy diet and leading a healthy counselling. lifestyle. Since cardiovascular diseases are one of the most common causes of PLIVA’s Mobile Doctor’s Office - a bus death in Croatia, and as the number of transporting healthcare providers - went to cardiovascular patients is continuously Priština, where about 500 citizens could increasing, these campaigns are focused have their blood pressure and glucose tested on education and prevention. PLIVA’s and, if necessary, get doctor’s advice. This public health campaigns were attended by event also has an added value, as the first several thousand people, who could have public health campaign organised outside of a free “check-up”, including have their Croatia, in Kosovo. Positive experiences and blood pressure and blood sugar tested, positive responses proved that this action receive free medical counselling on their was right on target. /035 Sponsorships and Donations Pliva Helps 1850 Parcels for 1850 Smiles PLIVA provides charitable contributions Almost two thousand children from all to a number of organisations throughout over Croatia rejoiced in gifts they received the year. One of them is “Osmjeh”, an from PLIVA for the Christmas holidays. organisation functioning as part of the PLIVA gave sweets, hats and scarves with Croatian Society for Optimisation of its logo to: Special Hospital for Medical Neurorisk Child Development, which very Rehabilitation Krapinske Toplice (there much appreciated PLIVA’s support in is also a primary school active at the purchasing a digital speech therapy set. hospital); Paloma from Vukovar; Down Syndrome Organisation; SANUS (for “Until recently we could not even think children with malignant diseases) from about purchasing such an expensive piece Split; “Nad Lipom” Primary School for of equipment, but you fulfilled both our Children with Disabilities in Zagreb; Zagreb and our little users’ wishes. A digital speech Association of the Blind; the Polyclinic therapy set helps in the rehabilitation for Hearing and Speech Rehabilitation of various speech disorders and in the SUVAG; Croatian Red Cross and the Zagreb rehabilitation of speech and hearing in Red Cross; Anđeli Association from Split; children with impaired hearing and cochlear Dystrophy Society; Autism Centre; Zagreb implants. Association of Dialysis Patients; Association Although innovative and state-of-the-art, Bedem ljubavi – for “Vinko Bek”, Children’s this equipment is easy to use: it digitally Home in Laduč and many others. processes sound signals with the almost Charity Action in Bosnia and Herzegovina same quality and at the almost same rate as the human brain. It is used in diagnostic procedures related We are especially glad that there is an In 2010 PLIVA’s charitable projects crossed to voice and speech, and in the differential increasing awareness about the necessity the Croatian borders. Instead of organising diagnosis of psychogenic dysphonia and of charity work among PLIVA employees. a cocktail party, our colleagues from stuttering. It is also used for treatment The initiative coming from a group of PLIVA’s Representative Office in Bosnia of various disorders affecting voice, employees to raise funds for the Special and Herzegovina decided to celebrate the pronunciation, fluency (stuttering and Hospital Bistra is a good example of their New Year’s holidays and mark the end of hastiness), hearing impairment (cochlear selfless engagement. All PLIVA employees yet another business year by organising implants), hearing processing impairment, gathered at the PLIVA People Day at the a charity event. They provided 4,700 developmental speech disorders, reading Jarun Lake could join this initiative, and hot meals and beverages to the public disorders, and ADHD. This set certainly PLIVA doubled the amount they raised. kitchens of the charities Merhamet, La helps speech therapists in raising the Benevolencija and Caritas, and for the quality of diagnosis and treatment. As Red Cross public kitchens. The meals our mission is to run a non-profit and and drinks were distributed in 31 public charitable organisation providing expert kitchens in three cities - Sarajevo, Banja support, it will help all those who need its Luka and Mostar, on 22 December. PLIVA’s assistance. Than you once again for your employees and business partners took part support”, said paediatrician Gordana Sušac. in this event. 036/ Sustainable Development Report 2010 /037 Product Responsibility Product Responsibility As drugs are products of special health importance, every country regulates this field in detail, and ensures strict quality control. This is carried out by domestic and international regulatory authorities that grant marketing authorisations and monitor drugs throughout their life cycles. Customer Health and Safety For PLIVA, the concept of quality is not limited to strict compliance with regulatory In order to ensure efficient, high quality requirements. It also implies company and safe drugs, the Medicinal Products Act awareness that only continuous care, has stipulated the procedure for testing ethical behaviour and continuous quality and marketing medicinal products as well improvements can prevent adverse events as methods for their manufacture, quality during all business processes and the control and compliance assessment. The entire drug lifecycle. This is the only way Croatian Ministry of Health is responsible to provide efficient, safe and high quality for supervising the supply of medicinal drugs to our customers. products to the Croatian market, while the Croatian Agency for Medicinal Products Information collected during drug and Medical Devices is responsible for development and verification of all issuing marketing authorisations and for indicators of efficiency and safety of pharmacovigilance processes. drugs within the regulatory approval process represent the first steps in the Drug quality is assured by implementation quality assurance of drugs. The materials of quality standards throughout a PLIVA uses (i.e. raw materials, active product’s life cycle. Quality standards, pharmaceutical ingredients, excipients, with which all manufacturers must intermediates, semi-finished products, comply, are known as Good Manufacturing packaging materials and finished products) Practices (GMPs), which are practices are carefully planned and controlled to be followed during the development, from purchasing, quality assessment, manufacture, quality control, warehousing production, and storage to distribution. and distribution of drugs. Manufacturers It is also important to ensure that key bear the greatest responsibility for drug outsourced services, which may impact quality, but all other participants in this on drug quality, comply with quality and chain are also responsible for the quality pharmaceutical industry requirements. of drugs, namely wholesalers, pharmacies, This process starts with the understanding and patients. of quality assurance processes of our suppliers and includes the formal Manufacturers must ensure the compliance assessment of their quality systems. In with all materials incorporated into addition to initial assessment, suppliers and the drug with quality requirements, service providers are monitored periodically, as well as production and in-process i.e. every two to three years. The purpose control in specially designed premises of this is to purchase materials and services and under stipulated conditions and of consistent quality and exclusively from written procedures, use of qualified and approved suppliers. appropriately designed equipment, training of production and quality control staff, However, our product care does not cease medical and sanitary safety examinations, upon regulatory approval and launch. written records evidencing all activities that Systematic monitoring of all events during are available during inspections, assurance the use of drugs, as well as keeping abreast of defined storage and distribution of literature data, all individual information conditions leading up to the delivery of related to the use of drugs and possible drugs to wholesalers, timely and efficient unexpected adverse reactions reported by market complaint handling procedures and, patients, is both our ethical and regulatory if necessary, the timely and efficient recall obligation. We pay careful attention to of drugs of inappropriate quality. market information about a possible 038/ Sustainable Development Report 2010 and unexpected side effect (false ones care for patients and for their health and Braille alphabet represents an added value included) as well as product complaints safety. The implementation of the quality for patients because instructions written in filed by regulatory institutions, inspection management system, state-of-the-art Braille on the majority of PLIVA’s leading authorities, patients or customers. technologies and talented and responsible drugs enable blind and visually impaired Therefore, incident management and employees guarantee product compliance people to use drugs properly. prevention is one of the most important with global quality standards and minimise Each packaging also contains a detailed chapters in our company’s quality system adverse events. leaflet with indications, contra-indications, interactions with other drugs, dosage manual. Product Labelling recommendations and methods of administering, precautions for use, adverse In line with written procedures, oral and written complaints on the quality of Every country defines its own drug reactions and procedures to follow in the marketed drugs are assessed, possible labelling requirements. In Croatia, drug event of overdose. causes are investigated, and measures labelling is governed by the Medicinal As one of the first companies in Croatia, for patient protection, including product Products Act. PLIVA strictly complies PLIVA introduced the Braille alphabet as recall if necessary, are evaluated. In this with the requirements given therein, i.e. early as in 1999 to some of its OTC drugs, way, we acquire new knowledge that we requirements stipulating that packaging and has since then extended this practice use to improve our processes and carry should indicate the product trade name, to all of its drugs. out preventive actions to avoid future chemical name, strength and form, complaints. Our company is characterised manufacturer, number of marketing by the correct management of these authorisation issued by the Agency for processes and rapid response to incident Medicinal Products and Medical Devices, PLIVA works hard to ensure timely and situations, which ensures continuous batch number, and expiration date. The quality market supply of its products. Complaint Handling Procedure /039 Product Responsibility In the event of delayed deliveries or and removal of all possible deviations and audited and are subject to continuous temporary product shortages due to the the procedure also includes feedback on assessment. PLIVA has an established reasons that cannot be anticipated, PLIVA measures taken. practice in supplier audits, additionally would take the necessary and appropriate There is also a toll-free telephone number intensified since October 2006 following measures to ensure the availability of that can be called; in addition, citizens can the adoption of the European directive necessary drugs for patients, including make inquiries by email. that stipulates the obligatory audits of API (active pharmaceutical ingredient) emergency imports. In the event of deviations in product Cooperation with Suppliers suppliers by drug manufacturers. The suppliers must enable these audits to be quality, pharmacies, wholesalers, patients and physicians may contact PLIVA, In its business operations PLIVA cooperates performed, which was not possible before which acts in accordance with defined with more than 1000 suppliers. It in a number of cases, especially in the procedures. Responsible persons should purchases raw and packaging materials case of large licences partners. Each audit record any complaint, adverse reaction or required for complex pharmaceutical includes a detailed inspection of the entire customer complaint, stating the name of production processes from more than 200 production process, including storage, the product, strength, and batch number suppliers. Domestic suppliers account for analytical labs and distribution, as well as printed on the packaging, and then a third of this number, and the rest are the corresponding documentation, in order forward this to PLIVA’s Sales Department foreign suppliers. to make a final decision on compliance with Good Manufacturing Practice to obtain relevant answers and to enable PLIVA to evaluate the complaint by All suppliers must comply with high quality (GMP). Through every audit and potential the subsequent research and analysis standards required for the pharmaceutical corrective actions, we upgrade the in Quality. This systematic complaint- industry. The entire operations of both quality of the materials we purchase and handling procedure enables identification new and long time suppliers are regularly incorporate into our finished products. 040/ Sustainable Development Report 2010 As far as the cooperation with suppliers PLIVA advertises and promotes its free advice offered by healthcare providers, is concerned, new opportunities can corporate brand to the public, and focuses and free blood pressure and blood sugar be anticipated in the formation of the an increasing number of activities on testing. anticipated pharmaceutical cluster. The patients and end users. Pursuing our vision Croatian Employers’ Association and and being aware of our responsibility to PLIVA continuously nurtures its corporate PLIVA initiated the formation of the the communities in which we operate, image, i.e. its brand, both through pharmaceutical cluster in Croatia in order to we work in cooperation with healthcare marketing activities and initiatives improve competitiveness and operations of institutions in Croatia on the prevention of and corporate communications in the pharmaceutical companies in Croatia. diseases and education of patients and the global and local environments. A good public to contribute to the improvement example of PLIVA’s intensive efforts is a The common and coordinated actions of of the quality of life and health of Croatian communication strategy that consists of companies and their business partners, citizens. Health and prevention have systematic communications with both the promotion of common interests, the been the topics of “Dedicated to Health,” external and internal audiences, general cooperation with other relevant clusters our several-month-long public health and target public groups, as well as its in the country and abroad, the common campaign. sponsorship, donation and advertising actions taken with regard to EU funds and The goal of this campaign, carried out in policies. “Dedicated to health” is one of state and local administration authorities, cooperation with various associations and our key public messages. It emphasises and the organisation and coordination organisations, has been to familiarise the PLIVA’s almost 90-year history and its of common promotion and market public with risk factors and provide advice efforts to improve quality of life and appearance are just some of a number of on diabetes and cardiovascular disease health by offering superior and affordable possible activities of this cluster. prevention through promotional materials, medicines. Marketing Communications Marketing communications related to prescription medicinal products in media and commercial channels in Europe, as well as in Croatia, are subject to stringent legal regulations. In Croatia, advertising and marketing communications related to drugs are regulated by the Ordinance on Advertising and Notifications about Medicinal Products, Homeopathic Products and Medical Devices. In communications with the general public, as well as with physicians and pharmacists, PLIVA abides by the provisions of the above ordinance both in the case of prescription and OTC (over the counter) drugs. To ensure compliance, PLIVA’s Legal Affairs department evaluates whether materials about medicinal products intended for physicians and pharmacists are in accordance with the Ordinance on Advertising and Notifications about Medicinal Products, Homeopathic Products and Medical Devices prior to their publication. /041 the Croatian Business Council for Sustainable Development Sustainable Development Committee and the Croatian Business Council for Sustainable Development PLIVA has confirmed the importance As one of its co-founders, PLIVA has carried Council member representatives exchange it attributes to employee care, process out sustainable-development activities knowledge and experience, promote safety, social responsibility and through the Croatian Business Council for efficient models and procedures, advocate environmental protection by founding Sustainable Development. Together with social responsibility, openness to the public the Sustainable Development Committee other Council members, PLIVA promotes and ecoefficiency (double effect – benefits in 2002. The Committee plans, directs economic growth based on corporate social for the economy and the environment), and coordinates activities relating to responsibility and environmental protection, and cooperate with members of other sustainable development, and drafts its supports sustainable development in social groups on sustainable-development annual Sustainable Development Reports economic, political, legal and social sectors, issues. to acquaint employees, business partners encourages changes that will facilitate and the community with its achievements the transition to sustainable development in this field. in Croatia, and represents the business sector in questions related to sustainable development both in Croatia and on the international level. PLIVA CROATIA Ltd. – a member of the Croatian Business Council for Sustainable Development 042/ SuStainable Development RepoRt 2010 Environmental Performance Indicators /043 044/ Sustainable Development Report 2010 Environmental Protection PLIVA is aware of the fact that its business results in an optimal harmonisation of addition to changes in our product portfolio, success and reputation also depend on its economic and environmental requirements. our production sites are also subject to environment. Therefore it has opted for We control our production processes and continuous changes. Consequently, for some business operations that respect and protect materials in accordance with the latest products, we choose sites that are more the environment and thus contributes to the knowledge and standards from the field of suitable for environmentally demanding preservation of health and the improvement environmental protection and thus ensure production processes. This means that the of the quality of life in the communities in compliance with the Croatian legislation and equipment we use in our production facilities which it operates. other stakeholders’ requirements. meets higher environmental standards, We control our production processes and along with an improved utilisation of raw Through our economic decisions and in materials in accordance with the latest materials and reuse of some substances. cooperation with the local community knowledge and standards from the field of Furthermore, we also have efficient facilities and the relevant state institutions we try environmental protection and thus ensure for the treatment of emissions and for to find the most suitable economic and compliance with the Croatian legislation and the prevention, treatment and control of environmental solutions that minimise our other stakeholders’ requirements. discharged wastewater quantities. Our environmental protection measures Over the last two years our production Through its actions PLIVA shows that it include monitoring, supervision and portfolio has undergone extensive changes. is a responsible company that wants to optimisation of our current business Some old technologies were replaced be a partner to the local community, a activities. They are also carried out with the new ones or with transferred company which takes care of the health of during the introduction of new products products with a different environmental its employees and the wider community and and technologies and the design and impact. We analyse all environmental a company that counts on the long-term reconstruction of our plants and facilities. aspects during each product transfer in development of its Savski Marof site, which Each investment is analysed with regard to order to ensure regulatory compliance and would definitely bring about many benefits its potential environmental impact, which maximum environmental protection. In to the local community as well. environmental impact. /045 Environmental Protection Water Consumption Therefore, the water consumption in Prilaz baruna Filipovića site uses both tap PLIVA CROATIA increased in 2010 due water and well water, the Savski Marof An increased water demand results from to increased production requirements. site uses the water from its own wells, the increased production at some sites, At its sites, PLIVA CROATIA uses either except for the preparation of food when and especially at the Savski Marof site. tap water and/or well water. While the they use tap water. Table 3 Water consumption in 2010 Site Water supply (m3) PLIVA’s own water wells (m3) Prilaz baruna Filipovića 336,959 195,960 Savski Marof 4,440 1,131,933 In order to optimise wastewater quality, only a slight increase in the volumes of PLIVA continuously improves the pre- discharged waste waters in comparison The methods for wastewater discharge treatment procedures for all production with 2009. and test indicators are defined by the plants. The goal of these improvements We continue to optimise our production water permit, separately for each PLIVA is to comply with any potentially more and wastewater pre-treatment processes site. Flow measurement and wastewater stringent regulatory requirements in the in order to reduce the total chemical analysis are carried out by both external future. oxygen demand (COD) of PLIVA’s Wastewater wastewater. However, COD levels in and in-house appointed laboratories in accordance with the schedule defined in Although production volumes 2010 were higher due to increased the water permit. significantly increased in 2010, there was production. Quantity of discharged process water Chemical Oxygen Demand (COD) m3/year t/year 2250000 2500 2000000 2000 1750000 1500 1500000 1000 1250000 500 1000000 0 2008 2009 2010 2008 2009 2010 046/ Air Emissions Sustainable Development Report 2010 Teva, which improved operations and doubled, entailing an increase in the increased production. Therefore the quantities of generated and disposed Almost all air emission values measured in company was divided into two production hazardous and non-hazardous waste in the reported period from stationary sources segments, i.e. Teva Pharma, which is PLIVA. were within the stipulated threshold limit exclusively focused on the production The diagrams below show the quantities values. of finished dosage forms and R&D, of generated and disposed non-hazardous and Teva Tapi Croatia, whose role is to and hazardous waste and the comparison produce active pharmaceutical ingredients over the last three years. Carbon Dioxide (CO2) Emissions (APIs). Consequently, the production Carbon dioxide, which plays the major role of pharmaceuticals in 2010 more than in the anthropogenic greenhouse effect causing global warming, is mainly produced by fuel combustion. Although energy requirements (production and heating) increased in 2010, we recorded a mild drop in carbon dioxide emissions, along with an increased efficiency in utility production, thanks to a different fuel and increased combustion Diagram 1 Quantities of disposed hazardous waste (2008 – 2010) tonnes efficiency. 1250.0 NOx, SOx and Other Emissions 1000.0 Wherever our infrastructure allows, we 750.0 almost exclusively use ground gas for energy production as it releases only CO2 and minimum quantities of other gases. Since we use this fuel, our annual emissions of NOx, CO and SO2 are very low. 500.0 732.1 969.2 1136.0 2009 2010 250.0 0 2008 Waste Management The period from 2008 to 2010 was marked by further changes in Croatian legislation. In accordance with these changes, PLIVA reorganised its operations in the field of waste management and Diagram 2 Quantities of disposed non-hazardous waste (2008 – 2010) tonnes 1250.0 continuously improved its hazardous and non-hazardous waste management. The 1000.0 employees in all production facilities were continuously trained accordingly, 750.0 and the authorised waste management contractors were audited. PLIVA also sought solutions in production processes in order to build a stronger, more effective and more cost-efficient waste management system in the company. This period was also marked by PLIVA’s takeover by the Israeli-based company 500.0 1044.0 997.6 119.6 2009 2010 250.0 0 2008 /047 Environmental Protection Diagram 1 does not reflect a continuous disposed non-hazardous waste increased cabinets. The campaigns were successfully trend of reduction in the quantities of by only approximately 12% in 2010 completed, and the citizens of Zagreb, generated and disposed hazardous waste compared to 2009. It also shows better Split and Primorje-Gorski Kotar County in 2009 and 2010. The reason lies in supervision, selection and on-site waste collected about 3600 kg of expired Teva’s takeover of the company at the preparation for disposal. medicines. The campaigns continued in beginning of 2009, and the consequent It should be mentioned that in line with Zagreb in 2011, and in 2012 we plan to introduction of a number of new products the Basel Convention, PLIVA exports all organise them in Osijek and in the Osijek- and phasing out of some old products. This its hazardous waste to Austria, Germany Baranja County. significantly increased production volumes and Hungary because Croatia still does and consequently the quantities of various not have facilities that would enable the Encouraged by the success of this types of process waste, and other types appropriate treatment of hazardous waste. campaign, in 2010 we placed containers of waste resulting from the write-off of In line with trends and legal requirements, for the continuous collection of expired finished product and raw material stocks. PLIVA audits authorised waste contractors medicines from our employees. We have (Figure 1). so far collected more than 100 kg of expired medicines, which clearly shows As production significantly increased, in some segments over 100%, we believe In 2009 and 2010 PLIVA started with the a high level of environmental awareness that a 55% increase in the quantity of replacement of asbestos-containing roofs, among our employees and citizens. At the generated hazardous waste in 2010 with which it passes over to authorised waste same time, we have upgraded our system regard to 2008 definitely does not reflect contractors. We plan to continue these for the collection of old batteries and the simultaneous increase in production. activities in 2011 and 2012, i.e. until we toners, which we send to be refilled. This This shows that the trend of on-site waste replace all asbestos-containing roofs. new system proved to be very practical and efficient because neither toners nor management, reduction of waste quantity per product unit, and reduction of total Over the past three years PLIVA, in batteries are disposed of as non-hazardous waste management costs has successfully cooperation with the competent city and waste. continued. This is best illustrated by the county authorities, initiated a number of fact that despite increased production campaigns for the collection and disposal volume, the quantity of generated and of expired medicines from home medicine Figure 1 A representative of CIAK d.o.o., Figure 2 Poster – the collection of expired Figure 3 Cleaning of the precipitation authorised contractor, collects batteries medicines from medicine cabinets and container by the authorised contractor at in PLIVA the new system for the collection of the Prilaz baruna Filipovića site batteries and toners 048/ Sustainable Development Report 2010 GRI (Global Reporting Initiative) Indicators PROFILE facilities, outsourced operations, and other entities that can 1. Strategy and Analysis significantly affect comparability from period to period and/or 1.1. Statement from the most senior decision maker of the between organizations organization about the relevance of sustainability to the 3.10. Explanation of the effect of any re-statements of organization and its strategy information provided in earlier reports, and the reasons for such re-statement 2. Organizational Profile 3.11. Significant changes from previous reporting periods in the 2.1. Name of the organization scope, boundary, or measurement methods applied in the report 2.2. Primary brands, products, and/or services 2.3. Operational structure of the organization, including main 4. Governance, Commitments, and Engagement divisions, operating companies, subsidiaries, and joint ventures 4.1. Governance structure of the organization, including 2.4. Location of organization’s headquarters committees under the highest governance body responsible for 2.5. Number of countries where the organization operates, and specific tasks, such as setting strategy or organizational oversight names of countries with either major operations or that are 4.2. Indicate whether the Chair of the highest governance body is specifically relevant to the sustainability issues covered in the also an executive officer report 4.3. For organizations that have a unitary board structure, state 2.6. Nature of ownership and legal form the number of members of the highest governance body that are 2.7. Markets served independent and/or non-executive members 2.8. Scale of the reporting organization 4.5. Mechanisms for shareholders and employees to provide 2.9. Significant changes during the reporting period regarding size, recommendations or direction to the highest governance body. structure, or ownership 4.14 List of stakeholder groups engaged by the organization 4.15. Basis for identification and selection of stakeholders with 3. Report Parameters whom to engage Report Profile 3.1. Reporting period ECONOMIC PERFORMANCE INDICATORS 3.2. Date of most recent previous report EC1 – Direct economic value generated and distributed, including 3.3. Reporting cycle revenues, operating costs, employee compensation, donations 3.4. Contact point for questions regarding the report or its and other community investments, retained earnings, and contents payments to capital providers and governments Report Scope and Boundary ENVIRONMENTAL PERFORMANCE INDICATORS 3.5. Process for defining report content Energy 3.6. Boundary of the report EN3 - Direct energy consumption by primary energy source 3.7. State any specific limitations on the scope or boundary of the EN4 - Indirect energy consumption by primary source report Water 3.8. Basis for reporting on joint ventures, subsidiaries, leased EN8 - Total water withdrawal by source /049 GRI indicators EN9 - Water sources significantly affected by withdrawal of Training and Education water LA10 - Average hours of training per year per employee by Emissions, Effluents and Waste employee category EN16 - Total direct and indirect greenhouse gas emissions by LA11 - Programs for skills management and lifelong learning weight. Diversity and Equal Opportunity EN17 - Other relevant indirect greenhouse gas emissions by LA13 - Composition of governance bodies and breakdown of weight. employees per category EN 20 - NO, SO, and other significant air emissions by type and weight. HUMAN RIGHTS PERFORMANCE INDICATORS EN21 - Total water discharge by quality and destination Non-discrimination EN22 - Total weight of waste by type and disposal method HR4 - Total number of incidents of discrimination and actions EN24 - Weight of transported, imported, exported, or treated waste taken deemed hazardous under the terms of the Basel Convention Products and Services PRODUCT RESPONSIBILITY PERFORMANCE INDICATORS EN26 - Initiatives to mitigate environmental impacts of products Customer Health and Safety and services, and extent of impact mitigation PR1 - Life cycle stages in which health and safety impacts of Overall products and services are assessed EN30 - Total environmental protection expenditures and Product and Service Labelling investments by type PR3 - Type of product and service information required by procedures, and percentage of significant products and services SOCIAL PERFORMANCE INDICATORS subject to such information requirements LABOR PRACTICES AND DECENT WORK Marketing Communications Employment PR6 - Programs for adherence to laws, standards, and voluntary LA1 - Total workforce by employment type, employment codes related to marketing communications, including advertising, contract, and region promotion, and sponsorship LA2 - Total number and rate of employee turnover by age group, gender, and region LA3 - Benefits provided to employees Occupational Health and Safety LA6 - Percentage of total workforce represented in formal joint management–worker health and safety committees LA7 - Rates of injury, occupational diseases, lost days, and absenteeism, and number of work related fatalities by region LA8 - Education, training, counselling, prevention, and riskcontrol programs in place to assist workforce members, their families, or community members regarding serious diseases 050/ Sustainable Development Report 2010 INDEX Contents GRI indicators INTRODUCTION From the President of the Management Board 1.1. ORGANISATIONAL PROFILE About PLIVA 2.1.-2.7. Management Board of PLIVA CROATIA Stakeholders REPORT PARAMETERS 3.5.-3.11. ECONOMIC PERFORMANCE INDICATORS Business Results for 2010 2.8. SOCIETY PERFORMANCE INDICATORS Awards Received by PLIVA in 2010 LA3 Human Resources Compensation and Benefits LA3 Scholarships and Practice LA3 EmploymentLA3 Diversity and Equal Opportunity LA13 Human Rights – Non-Discrimination HR4 Science and Education Applications for Mobile Phones LA11 On-line Courses LA11 Employee Care Health and Safety Safety at Work Occupational Safety and Health Management System Occupational Safety and Health Implementation Risk Assessment LA6 /051 INDEX Contents GRI indicators Internal Audits External Audits Training Reporting Health Protection Employee Motivation Occupational Safety and Health Status LA7 Health and Disability Care LA8 Flue Vaccination LA8 PLIVA’s Blood Donation Volunteers LA8 Christmas Lunch and Party for Employees After-work Party on Fridays Sponsorships and Donations PLIVA Helps LA8 1850 Parcels for 1850 Smiles LA8 Charity Action in Bosnia and Herzegovina LA8 Product Responsibility Customer Health and Safety PR1 Product Labelling PR3 Complaint Handling Procedure Cooperation with Suppliers Marketing Communications PR6 Sustainable Development Committee and the Croatian Business Council for Sustainable Development PR6 ENVIRONMENTAL PERFORMANCE INDICATORS Environmental Protection Water Consumption EN9 WastewaterEN21 Air Emissions Waste Management EN20 EN22, EN24 PLIVA CROATIA Ltd. – a member of the Croatian Business Council for Sustainable Development www.pliva.hr www.plivazdravlje.hr
© Copyright 2024 Paperzz